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    方法：采用小鼠胰岛 β细胞株 MIN6 细胞作为体外研究胰岛细胞的对象。
分别在含有不同浓度的依维莫司、地磷莫司、佐他莫司培养基中孵育 MIN6
细胞 24h、48h。将溶剂无水乙醇处理的 MIN6 细胞设为阴性对照组，环孢素
A 和三氧化二砷处理的 MIN6 细胞设为阳性对照组，观察三种雷帕霉素衍生
物对 MIN6 细胞的增殖、细胞活力、细胞周期、凋亡的影响。 




















性对照相比组，呈现抑制 G1 期向 S 期转变的趋势和促进细胞凋亡的趋势，
但差异没有统计学意义。 























Background: The exploration and application of the immunosupressants always 
has been promoting the development of the field of organ transplantation. Since 
the early 21th century, islet transplantation achieved the extraordinary leap after the 
Edmonton protocol coming out, especially the tacrolimus and rapamycin. However, 
the researchers found that the immunosupressants not only prolong the islet 
transplantation graft survival, but also have the detrimental effects on islet 
proliferation, survival and function. Evidence for pancreatic β-cell toxicity - 
hyperglycemia can be reported in anti-tμmor therapy. So, it is a huge challenge that 
how to avoid the β-cell toxicity of immunosuppressive agent. Once the destruciton of 
the islet function appearing, the patients will be up against the second transplantation 
or continue to inject insulin. Though Rapamycin is one of the most common 
immunosuppresant in islet transplantaion, there have been a nμmber of studies 
investigating the direct effects of rapamycin on pancreatic β-cell function,  survival, 
and proliferation. The fact makes us seek for the much more immunosuppresants to 
change the situation.Rapalogs include everolimus，deforolimus， zotarolimus，
temsirolimus. These rapalogs are commonly used in anti-tμmor therapy, and 
everolimus have been simultaneously applied to the anti-organ transplant rejection. At 
present,there is few studies about these derivatives whether the same toxicity as the 
rapamycin on islet β cell.In this work, we develop a method in vitro with cell lines to 
study the effect on islet of everolimus，deforolimus and zotarolimus. 
Method: The mouse pancreatic β cell line MIN6 cell is our research object. We 
treated MIN6 cell in different concentrations and incubated for 24 hours and 48 hours. 
The ethanol-treated MIN6 cell was to be negative group, and cyclosporin A and 
arsenic trioxide group were to be positive control. MIN6 cell proliferation were 
detected by BrdU and cell viability were detected by CCK8. The cell cycle and 
apoptosis were analyzed by FACS. 















would be inhibited when the concentration increased to 1ng/ml and the concentration 
was dose-dependent manner. Bisidses, the effect of the three kinds of derivatives on 
MIN6 inhibiton were more significant than rapamycin. In the cell viability assay, the 
concentration at 100ng/ml of rapalogs could significantly inhibited cell viability. 
However,zotarolimus effected on cell viability at 10ng/ml. The percent of G1 
population in rapalogs group were higher than ethanol group by FACS, but the 
difference was not statistically significant.So did apotosis cells. 
Conclusion: We got a better understanding of these derivatives of rapamyicin 
that all of them could inhibit the proliferation of MIN6 cell and cell viability. And, we 
found that it is more obviously that the rapalogs effected the proliferaion and cell 
viability than rapamycin. Thus, we thought that the toxicity of  the rapalogs were 
worse than rapamycin. Whether the rapalogs could replace the rapamycin in 
Edmonton protocol need further study. This result provides a prosiming advice for 
further development and clinical application. 
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糖尿病临床上分为两型，即Ⅰ型糖尿病（Type 1 diabetes mellitus，T1DM ）
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